Penicillin Allergy Delabeling: An Antibiotic Stewardship Initiative

Penicillin Allergy Delabeling: An Antibiotic Stewardship Initiative

Original release date: June 11, 2024; Termination date: May 16, 2027.

View the Webinar

 

Handouts
Download the webinar slides as full page slides or in handout format.

 

Continuing Education Credit(s)
This webinar has been approved for 1 AMA PRA Category 1 Credit™.
To request a certificate, you must first view the webinar and then complete this form.

  • Physicians will receive a CME Certificate
  • Other learners will receive a Certificate of Attendance. This meets the continuing education requirements of many boards.

 

Webinar Overview
This activity is designed for healthcare providers including physicians and pharmacists. Topics included are an update on recent guidelines for addressing penicillin allergy; the benefits of penicillin allergy delabeling; and identifying appropriate candidates for oral amoxicillin challenge. Participants should become familiar with safe and effective ways to delabel patients identified as penicillin allergic who are admitted to the hospital.

 

Target Audience
This activity is designed for healthcare providers including physicians, pharmacists, infection preventionists or other facility antibiotic stewardship stakeholders.

 

Learning Objectives
At the conclusion of the webinar, participants will will feel more confident in their ability to:

  1. Discuss the risks of having a penicillin allergy label.
  2. Obtain a penicillin allergy history to determine risk of new/repeated allergic reaction upon administration of penicillin.
  3. Safely perform an amoxicillin challenge.
  4. Proactively remove a patient’s penicillin allergy label when appropriate.
  5. Implement a penicillin allergy delabeling process and program.

 

Webinar Presenter
Shazia Lutfeali, MD,

Shazia Lutfeali, MD, Allergy and Immunology Assistant Professor, Departments of Medicine and Pediatrics Cedars-Sinai Medical Center.

Dr. Lutfeali treats both hospitalized and clinic patients with a variety of allergic and immunologic conditions including drug allergies, food allergies, environmental allergies, chronic hives, severe asthma, and atopic dermatitis. During her training, she developed a strong interest in drug allergy and specifically the importance of penicillin allergy delabeling. Her research focused on rates of penicillin allergy relabeling and methods to prevent inappropriate allergy relabeling.

 

Resources for Further Study
LAC DPH Penicillin Allergy Delabeling Toolkit for Hospitals
LAC DPH Antimicrobial Stewardship Program homepage

 

Accreditation Statement

California Medical Association accredited CME provider logo The Los Angeles County Department of Public Health is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

The Los Angeles County Department of Public Health designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other learners may receive a Certificate of attendance. According to the California Board of Registered Nursing, Continuing Medical Education is acceptable for meeting RN continuing education requirements, as long as the course is Category 1, and has been taken within the appropriate time frames.

 

Disclosure
No relevant financial relationships were disclosed by the authors or the planners. This activity is offered by an accredited CMA-CME provider and is not commercially supported.

 

Contact Information
Contact the Public Health Antibiotic Stewardship Program at Stewardship@ph.lacounty.gov